Skip to main content
SpringerLink
Log in

Durchblutungsfördernde Mittel

  • Chapter
Arzneiverordnungs-Report 2012

  • 1323 Accesses

Zusammenfassung

Durchblutungsfördernde Mittel haben ihre einst führende Position bei der Behandlung peripherer arterieller Durchblutungsstörungen verloren. Seit 1992 ist das Verordnungsvolumen um 92% zurückgegangen. Damit wurde die praktische Arzneitherapie kontinuierlich an die neuen therapeutischen Möglichkeiten angepasst.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Antithrombotic Trialists' Collaboration (2002): Collaborative meta-analysis of ran- domised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Brit Med J 324: 71-86.

    Article  Google Scholar 

  • Arain FA, Cooper LT (2008): Peripheral arterial disease: diagnosis and management. Mayo Clin Proc 83: 944-949

    PubMed  Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2004): Empfehlungen zur Therapie der peripheren arteriellen Verschlusskrankheit (pAVK). 3. Auflage. Arzneiverordnung in der Praxis, Band 31 Sonderheft 3. Im Internet unter: www.akdae.de/35/72_ pAVK_2004_3Auflage.pdf

  • Barradell LB, Brogden RN (1996): Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease. Drugs Aging 8: 299-322.

    Article  PubMed  CAS  Google Scholar 

  • Conlin AE, Parnes LS (2007a): Treatment of sudden sensorineural hearing loss: I. A sys- tematic review. Arch Otolaryngol Head Neck Surg 133: 573-581.

    Article  Google Scholar 

  • Conlin AE, Parnes LS (2007b): Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 133: 582-586.

    Article  Google Scholar 

  • Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie (2010): Hörsturz (Akuter idiopathischer sensorineuraler Hörverlust). Internet: www. awmf.org/uploads/tx_szleitlinien/017-010l_S1_Hoersturz.pdf

  • Espinola-Klein C (2011): Periphere arterielle Verschlusskrankheit. Internist 52: 549-561.

    Article  PubMed  CAS  Google Scholar 

  • Gutacker N, Neumann A, Santosa F, Moysidis T, Kröger K (2010): Amputations in PAD patients: data from the German Federal Statistical Office. Vasc Med 15: 9-14.

    Article  PubMed  Google Scholar 

  • Hiatt WR (2002): Pharmacological therapy for peripheral arterial disease and claudica- tion. J Vasc Surg 36: 1283-1291.

    Article  PubMed  Google Scholar 

  • Hiatt WR, Krantz MJ (2006): Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication. Vasc Med 11: 55-60.

    Article  PubMed  Google Scholar 

  • Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B (2006): ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary: a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease). J Am Coll Cardiol 47: 1239-312.

    Article  PubMed  Google Scholar 

  • Housley E (1988): Treating claudication in five words. Brit Med J 296: 1483-1484.

    Article  CAS  Google Scholar 

  • Gutacker N, Neumann A, Santosa F, Moysidis T, Kröger K (2010): Amputations in PAD patients: data from the German Federal Statistical Office. Vasc Med 15: 9-14.

    Article  PubMed  Google Scholar 

  • Klemm E, Bepperling F, Burschka MA, Mösges R; Study Group (2007): Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients. Otol Neurotol 28: 157-170.

    Article  PubMed  Google Scholar 

  • McDermott MM, Liu K, Ferrucci L, Criqui MH, Greenland P, Guralnik JM, Tian L, Schneider JR, Pearce WH, Tan J, Martin GJ (2006): Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more. Ann Intern Med 144: 10-20.

    PubMed  Google Scholar 

  • Mösges R, Köberlein J, Heibges A, Erdtracht B, Klingel R, Lehmacher W; for the RHEO- ISHL Study Group (2009): Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol 266: 943-953.

    Article  PubMed  Google Scholar 

  • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E 3rd, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K (2007): Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg Suppl 1: S1-75.

    Article  Google Scholar 

  • Pedersen TR, Kjekshus J, Pyörälä K, Olsson AG, Cook TJ, Musliner TA, Tobert JA, Haghfelt T (1998): Effect of Simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 81: 333-335.

    Article  PubMed  CAS  Google Scholar 

  • Probst R, Tschopp K, Ludin E, Kellerhals B, Podvinec M, Pfaltz CR (1992): A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol 112: 435-443.

    Article  PubMed  CAS  Google Scholar 

  • Robless P, Mikhailidis DP, Stansby GP (2008): Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003748

    Google Scholar 

  • Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E (2006): Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354: 1879-1888.

    Article  PubMed  CAS  Google Scholar 

  • Schreiber BE, Agrup C, Haskard DO, Luxon LM (2010): Sudden sensorineural hearing loss. Lancet 375: 1203-1211.

    Article  PubMed  Google Scholar 

  • Squires H, Simpson E, Meng Y, Harnan S, Stevens J, Wong R, Thomas S, Michaels J, Stansby G (2011); A systematic review and economic evaluation of cilostazol, nafti- drofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermit- tent claudication in people with peripheral arterial disease. Health Technol Assess 15: 1-210.

    PubMed  CAS  Google Scholar 

  • Transparenzkommission (1983): Transparenzliste für das Teilgebiet periphere arterielle Durchblutungsstörungen. Bundesanzeiger Nr. 169 vom 9.9.1983.

    Google Scholar 

  • Watson L, Ellis B, Leng GC (2008): Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008 Oct 8; (4): CD000990.

    Google Scholar 

  • Wei BP, Mubiru S, O'Leary S (2006): Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003998. Review.

    Google Scholar 

  • Weinaug P (1984): Die Spontanremission beim Hörsturz. HNO 32: 346-351.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Neuenheimer Feld 366, 69120, Heidelberg

    Prof. Dr. med. Ulrich Schwabe

Authors
  1. Prof. Dr. med. Ulrich Schwabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Medizin Verlag Berlin, Heidelberg

About this chapter

Cite this chapter

Schwabe, U. (2012). Durchblutungsfördernde Mittel. In: Arzneiverordnungs-Report 2012. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29242-2_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-29242-2_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-29241-5

  • Online ISBN: 978-3-642-29242-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation